Search

Laboratorios Farmaceuticos Rovi SA

Closed

SectorHealthcare

58.35 1.3

Overview

Share price change

24h

Current

Min

57.6

Max

58.8

Key metrics

By Trading Economics

Income

80M

89M

Sales

39M

192M

P/E

Sector Avg

15.925

56.432

EPS

1.466

Dividend yield

1.67

Profit margin

46.582

Employees

2,470

EBITDA

83M

101M

Dividends

By Acuity

Dividend yield

Sector Avg

1.67%

2.27%

Next Earnings

5 lis 2026

Market Stats

By TradingEconomics

Market Cap

174M

2.9B

Previous open

57.05

Previous close

58.35

News Sentiment

By Acuity

59%

41%

273 / 339 Ranking in Healthcare

Laboratorios Farmaceuticos Rovi SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 wrz 2026, 23:56 UTC

News

Lululemon Athletica shares are lower in after-market hours amid an investigation into potential securities law violations following a revenue guidance cut.

15 wrz 2026, 23:41 UTC

Correlated Moves
News

Heartland Express shares are lower in after-market trading, influenced by declines in Schneider National and concerns from the New York Empire State Manufacturing Index.

15 wrz 2026, 23:41 UTC

Correlated Moves
News

Tower Semiconductor shares are lower in after-market hours amid broader market dynamics and rising treasury yields ahead of the Federal Reserve's policy decision.

15 wrz 2026, 23:31 UTC

News

Xylem Inc. shares declined in after-market hours following a $1.5 billion senior notes offering, reflecting broader market trends and shifting investor sentiment.

15 wrz 2026, 23:26 UTC

News

Phil Poliquin has been appointed senior vice president at United Bankshares, focusing on government contracting. Shares are roughly flat in after-market trading.

15 wrz 2026, 23:16 UTC

News

FedEx shares are lower in after-market trading following the appointment of Mike Rodgers as Chief Commercial and Technology Officer amid broader market pressure.

15 wrz 2026, 23:16 UTC

News

Royalty Pharma announced a $7.5 million donation to Blood Cancer United. Shares are lower in after-market trading amid rising Treasury yields.

15 wrz 2026, 23:11 UTC

News

Coca-Cola Europacific Partners PLC gains in after-market hours on a planned $10 billion investment in U.S. infrastructure through 2030, focusing on production and distribution.

15 wrz 2026, 23:06 UTC

News

FuelCell Energy shares rise in after-hours trading following insider purchases. Director John Livingston bought 26.3K shares for $247K on September 14.

15 wrz 2026, 23:06 UTC

News

Apple Inc. shares rose in after-market trading following a product event that introduced new offerings and received an "Overweight" rating from Morgan Stanley with a $360 target.

15 wrz 2026, 23:06 UTC

Correlated Moves
News

Blackstone Inc's shares are higher in after-market trading, likely influenced by KKR & Co Inc's recovery and recent IPO activity highlighted by CFO Michael Chae.

15 wrz 2026, 23:06 UTC

News

UnitedHealth Group will release third quarter 2026 results on October 13. Shares are trading higher in after-market hours, reflecting a modest gain.

15 wrz 2026, 23:06 UTC

News

Intuit Inc reported full-year revenue of $21.4 billion, a 14% increase. Shares are higher in after-market trading following the results and positive sentiment.

15 wrz 2026, 23:02 UTC

News

Walmart shares rose in after-market trading following a 5.1% growth in global enterprise, surpassing its average target and reflecting strong consumer spending.

15 wrz 2026, 23:02 UTC

News

Permian Resources shares are higher in after-market trading, with a current price of $24.49, reflecting strong long-term performance and a market cap of $20.51 billion.

15 wrz 2026, 23:02 UTC

News
Social Media

RTX shares are higher in after-market trading following the appointment of Jill Albertelli as president of Pratt & Whitney, effective January 1, 2027.

15 wrz 2026, 23:02 UTC

Correlated Moves
News

Chevron Corp shares are lower in after-market hours, influenced by a drop in the New York Empire State Manufacturing Index and ongoing supply risks.

15 wrz 2026, 23:02 UTC

News
Event

Trip.com Group Ltd reported second-quarter EPS of $1.07, exceeding expectations, while shares rose in after-market trading following the earnings announcement.

15 wrz 2026, 23:02 UTC

News

Target Corp shares are trading higher in after-market hours following the announcement of a new employee apparel line designed by Isaac Mizrahi.

15 wrz 2026, 23:02 UTC

Social Media
News

Celsius Holdings Inc. shares rose in after-hours trading following significant insider purchases totaling around $1 million by Director Damon DeSantis.

15 wrz 2026, 23:02 UTC

Correlated Moves
News

Qualcomm's after-market trading remains stable, reflecting Nasdaq 100 trends. The company reported $9.9 billion in revenue for the fiscal third quarter.

15 wrz 2026, 23:02 UTC

News

CrowdStrike Holdings shares are lower in after-market hours amid negative sentiment following a sharp decline in the New York Empire State Manufacturing Index.

15 wrz 2026, 23:02 UTC

News

Radiant Logistics shares are higher in after-market trading despite Glencore's $2 billion lawsuit alleging fraud and terminating business relationships with Radiant World.

15 wrz 2026, 23:02 UTC

Correlated Moves
News

Coinbase Global shares are lower in after-hours trading, influenced by declines in Bitcoin and Bitmine Immersion Technologies, amid a weak overall trading environment.

15 wrz 2026, 23:01 UTC

News

Boeing's recent Pentagon agreements include a $13.4 billion expansion of the KC-46 contract, though shares traded roughly flat in after-market hours.

15 wrz 2026, 23:01 UTC

News
Event

Evolution Petroleum shares are higher after reporting fourth-quarter revenue of $24.21 million, exceeding expectations, though adjusted EPS missed consensus estimates.

15 wrz 2026, 23:01 UTC

News

Interactive Brokers Group has integrated with X Cashtags, enabling US users to trade directly from tagged stock and crypto symbols. Shares are higher in after-market hours.

15 wrz 2026, 23:01 UTC

News

D.R. Horton announced a $5 billion stock repurchase program and raised its fiscal 2026 buyback target to $3.25 billion, contributing to after-market gains.

15 wrz 2026, 23:01 UTC

News

Alignment Healthcare Inc. shares are lower in after-market hours as bipartisan lawmakers introduce the Protecting Approved Care Act, impacting Medicare Advantage plans.

15 wrz 2026, 23:01 UTC

News

Coca-Cola Co plans a $10 billion investment in U.S. infrastructure by 2030. Shares showed little change during after-market hours, reflecting stable trading conditions.

Peer Comparison

Price change

Laboratorios Farmaceuticos Rovi SA Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

273 / 339 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
help-icon Live chat